Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients
Clinical trial NCT01884441 · UNKNOWN
Trial details
- NCT number
- NCT01884441
- Sponsor
- Armando Santoro, MD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2014-07-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.